ABCG2 and breast carcinoma: The second member of subfamily G, ABCG2, was originally cloned from a doxorubicin-resistant breast cancer cell line where resistance independent of ABCB1 was strategically sought out by selecting for drug resistance in the presence of a ABCB1 inhibitor (Doyle et al., 1998).